Awards for Scientific Publications

Awards for Scientific Communications

PhD Thesis Awards

Grants

1. Top-10 most cited articles published in Bioorganic and Medicinal Chemistry Letters (2011-2012), by article “Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors”, A. Gaspar, J. Reis, A. Fonseca, N. Milhazes, D. Viña, E. Uriarte, Borges. Bioorg. Med. Chem. Lett., 2011, 21 (2): 707-9.
2. Top-10 most cited articles published in ChemMedChem (2012), by article “8-Substituted-3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation and docking studies”, D Viña, MJ Matos, G. Ferino, E Cadoni, R Laguna, F Borges, E Uriarte, L Santana. ChemMedChem 2012, 7, 464-470.
3. Annual Award of the Cuban Academy of Sciences to the results in the Scientific Research: “From molecular structure biological activity: Applications and potentialities of novel computational design methods in QSAR, QSPR, QSPkR, QSTR studies, proteomic and bioinformatics”
4. Highly cited paper by web of science (received enough citations to place it in the top 1% of the academic field of Chemistry based on a highly cited threshold for the field and publication year) by article Gaspar, M. J. Matos, J. Garrido, E. Uriarte, F Borges “Chromone: a valid scaffold in medicinal chemistry”, Chem. Rev., 2014, 114 (9), 4960-4992.
5. Highly cited paper by web of science (received enough citations to place it in the top 1% of the academic field of Chemistry based on a highly cited threshold for the field and publication year) by article M.F. Roleira, E.J. Tavares-da-Silva, C.L. Varela, S.C. Costa, T. Silva, J. Garrido, F. Borges, “Plant derived and dietary phenolic antioxidants: anticancer properties”, Food Chem., 2015, 183, 235-258.
6. Highly cited paper by web of science (received enough citations to place it in the top 1% of the academic field of Chemistry based on a highly cited threshold for the field and publication year) by article Reis J, Gaspar A, Milhazes N, Borges F.Chromone as a privileged scaffold in drug discovery: recent advances. J Med Chem. 2017, ;60(19), 7941-7957.

1. I. M. Oliveira, A. Borges, F. Borges, M. Simões, “The effects of ibuprofen on Staphylococcus aureus biofilm control”, 3rd International Caparica Conference in Antibiotic Resistance (IC2AR). Shotgun Session II, Lisbon (Portugal), 10^th-13^rd June 2019

2. F. Mesiti, A. Gaspar, D. Chavarria, C. Fernandes, R. Silva, S. Alcaro, F. Borges, “Mapping the chromone-3-phenylcarboxamide pharmacophore: structure-activity-toxicity and efflux transport studies”, 4^th WG meeting – MuTaLig COST Action. Faculty of Pharmacy, Ege University, Izmir (Turkey), 5-6 ^th March 2020

3. R. Amorim, J. Teixeira, S. Benfeito, F. Cagide, P.J. Oliveira, F. Borges, “Mitochondriotropic Cinnamic Acid Antioxidant Improves Cellular Resistance to Stress”, 4^th WG meeting – MuTaLig COST Action. Faculty of Pharmacy, Ege University, Izmir (Turkey), 5-6^th March 2020

1. K. Santos, J. Teixeira, R. Amorim, F. Cagide, F. Borges, P.J. Oliveira, “New paradigms in anticancer combined therapy: Targeting dietary antioxidants to mitochondria”, 49^th Annual Scientific Meeting of the European Society for Clinical Investigation, Cluj-Napoca (Romania), 27-30^th May 2015
2. S. Benfeito, F. Remião E. Uriarte, F. Borges, “Development of bifunctional agents for ameliorating the oxidative stress associated with aging related diseases”, 36^th Edition of the European School of Medicinal Chemistry (ESMEC), Urbino (Italy), June 26th-July 1st 2016
3. J. Teixeira, R. Amorim, R. Carreira, F. Cagide, S. Benfeito, F. Borges, P.J. Oliveira, “Effects of multi-operational mitochondria-targeted antioxidants in human hepatic cells: promising drugs for liver disease”, 52^nd Annual Meeting of the European Society for Clinical Investigation, Barcelona (Spain), 29^th May-1^st June 2018
4. P. Soares, C. Oliveira, S. Benfeito, F. Cagide, C. Fernandes, J. Teixeira, R. Amorim, P. J. Oliveira, F. Borges, “From nature inspiration to multitarget small molecules: upgrading the activity of dietary cinnamic and benzoic acids for the treatment of neurodegenerative disorders”, 3rd WG meeting, MuTaLig COST ACTION CA15135, Paris (France), 23-24^th February 2019
5. P. Soares, C. Silva, F. Silva, M. Batie, C. Oliveira, F. Cagide, P.J. Oliveira, S. Rocha, F. Borges,“1-Mitochondriotropic antioxidants as novel therapeutics for Amyotrophic Lateral Sclerosis: development of multitarget agents to prevent stress induced motor neurons death”, 3rd WG meeting, MuTaLig COST ACTION CA15135, Paris (France), 23-24^th February 2019
6. D. Chavarria, C. Fernandes, V. Silva, E. Gil-Martins, R. Silva, F. Remião, P.J. Oliveira and F. Borges, “2-Design and development of piperine derivatives acting as potent MAO-B inhibitors and mild P-gp inhibitors”, 3rd WG meeting, MuTaLig COST ACTION CA15135, Paris (France), 23-24^th February 2019

2014

• Chromone: a valid scaffold in medicinal chemistry
  Alexandra Gaspar, University of Porto (Portugal)

2016 

• Hydroxycinnamic acid as a valid scaffold for the development of CNS multitarget drugs
  Tiago Silva, University of Porto (Portugal)
• Targeting dietary antioxidants to mitochondria as a therapeutic solution for mitochondrial oxidative stress related diseases
  José Teixeira, University of Porto (Portugal)

2017

• Discovery of target directed drugs for neurodegenerative diseases based on benzopyrone scaffold
  André Fonseca, University of Porto (Portugal)

2018

• Benzoic acid as a valid scaffold for the development of dual-target directed drugs for Alzheimer’s disease
  Catarina Oliveira, University of Porto (Portugal)
• Single and multi-target agents for neurodegenerative diseases based on the chromone scaffold
  Joana Reis, University of Porto (Portugal)

2019

• Development of PEGylated platforms to overcome blood–brain barrier constraints in neurodegenerative therapy
  Carlos Fernandes, University of Porto (Portugal)
• Design and development of multi-target agents for neurodegenerative diseases
  Sofia Benfeito, University of Porto (Portugal)

2014

• Cumarinas: Versatilidade estrutural e aplicacións en Química Farmacéutica
  Maria João Matos, University of Santiago de Compostela

2010

• European Federation for Medicinal Chemistry (EFMC) fellowship
  European School of Medicinal Chemistry- ESMEC, Urbino, Italy, 26th June- 1st July, 2010
  Maria João Matos, University of Porto (Portugal)
  Webpage
• XXI International Symposium on Medicinal Chemistry (EFMC-ISMC) grant
  Brussels, Belgium, 5-9th September, 2010
  Maria João Matos, University of Porto (Portugal)
  Webpage
• Sociedade Espanhola de Química Terapêutica (SEQT) grant
  IX Jornadas de la SEQT – New perspective and emerging technologies in drug discovery, Baeza, Spain, 11st-12nd November, 2010
  Maria João Matos, University of Porto (Portugal)
  Webpage

2011

• Sociedade Espanhola de Química Terapêutica (SEQT) grant
  XVI Congreso de la SEQT – From a Classical to a New Age in Medicinal Chemistry, Valencia, Spain, 18-21th September, 2011
  Maria João Matos, University of Porto (Portugal)
  Webpage
• Real Sociedad Española de Química grant
  VIII Simpósio Investigadores Jóvenes RSEQ- Sigma-Aldrich, Torremolinos, Málaga, 25-28th October, 2011
  Maria João Matos, University of Porto (Portugal)
  Webpage

2012

• ADDF Young Investigator Scholarship grant from Alzheimer’s Drug Discovery Foundation
  6th Drug Discovery for Neurodegeneration conference: An intensive Course on Translating Research into Drugs, New York, USA, 12-14th February, 2012
  Alexandra Gaspar, University of Porto (Portugal)
  Joana Reis, University of Porto (Portugal)
  Tiago Silva, University of Porto (Portugal)
  José Teixeira, University of Porto (Portugal)
  Webpage

2013

• Universidade de Santiago de Compostela grant
  Frontiers in Medicinal Chemistry, San Francisco, USA, 23-26th June, 2013
  Maria João Matos, University of Porto (Portugal)
  Webpage

• Sociedade Espanhola de Química Terapêutica (SEQT)- 3rd Summer School:
  “Medicinal Chemistry in Drug Discovery: the Pharma Perspective, Madrid, Spain, 25-27 June, 2013
  Alexandra Gaspar, University of Porto (Portugal)
  Webpage
• European Federation for Medicinal Chemistry (EFMC) fellowship
  European School of Medicinal Chemistry- ESMEC, Urbino, Italy, 26th June- 1st July, 2013
  Tiago Silva, University of Porto (Portugal)
  Webpage

2014

• Sociedade Espanhola de Química Terapêutica (SEQT)- 4th GSK Summer School grant:
  “Medicinal Chemistry in Drug Discovery: the Pharma Perspective, Madrid, Spain, 25-27th June, 2014
  Salette Vasquez, University of Santiago Compostela (Spain)
  Webpage
• European Federation for Medicinal Chemistry (EFMC) fellowship
  European School of Medicinal Chemistry- ESMEC, Urbino, Italy, 25-30th June, 2014
  Joana Reis, University of Porto (Portugal)
  Webpage

• XXIII International Symposium on Medicinal Chemistry (EFMC-ISMC) grant
  Lisbon, Portugal, 7th-11nd September, 2014
  Maria João Matos, University of Porto (Portugal)
  Webpage

• 10th Spanish-Italian Symposium on Organic Chemistry
  Firenze, Italy, 17-20 July, 2014
  Maria João Matos, University of Porto (Portugal)
  Webpage

2016

• European Federation for Medicinal Chemistry (EFMC) fellowship
  European School of Medicinal Chemistry- ESMEC, Urbino, Italy, 26th June- 1st July, 2016
  Carlos Fernandes, University of Porto (Portugal)
  Webpage

2017

• ITC Conference Grant from COST – (Action CA15135)
  7th meeting of Paul Ehrlich MedChem EuroPhD Network, Vienna, Austria, 25-27th August, 2017
  José Teixeira, University of Porto (Portugal)
  Webpage

• MuTaLig COST Action (CA15135) – Short-Term Scientific Missions grant
  2017
  Joana Reis, University of Pavia (Italy) – 3 months
  Title: “Crystallographic and biochemical studies of multitarget chromone-based inhibitors of monoamine oxidase-B for the treatment of Alzheimer’s disease”

  Anabela Portela Borges, University of Cagliari (Italy) – 3 months
  Title: “In silico studies of new quorum-quenching compounds based on a brominated nitrovinylfuran to combat Pseudomonas aeruginosa infections”

  Webpage

2018

• MuTaLig COST Action (CA15135) – Short-Term Scientific Missions grant
  2018
  Francesco Mesiti, University of Catanzaro (Italy) – 3 months
  Title:” Design and Development of Dual -Target Ligands Based on Benzopyran for the Treatment of Parkinson’s Disease”
  Webpage
• 3rd MuTaLig COST Action Training School – MuTaLig COST Action, Fraunhofer IME Screening Port
  Hamburg, Germany, 5-7th December, 2018
  Sofia Benfeito, University of Porto (Portugal)
  Daniel Chavarria, University of Porto (Portugal)
  Catarina Oliveira, University of Porto (Portugal)
  Webpage

2019

• 26th Young Research Fellows Meeting (YRFM)
  Paris, France, 20th-22nd February, 2019
  Daniel Chavarria, University of Porto (Portugal)
  Webpage
• 3rd MuTaLig COST Action Training School – MuTaLig COST Action, Fraunhofer IME Screening Port
  2nd edition (EU), Hamburg, Germany, 6-8th March, 2019
  Tiago Silva, University of Porto (Portugal)
  Lisa Sequeira, University of Cagliari (Italy)
  Daniel Martins, University of Porto (Portugal)
  Miguel Pinto, University of Porto (Portugal)
  Francesco Mesiti, University of Catanzaro (Italy)
  Webpage